Neuromyelitis Optica
48
2
6
22
Key Insights
Highlights
Success Rate
81% trial completion
Published Results
12 trials with published results (25%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
10.4%
5 terminated out of 48 trials
81.5%
-5.0% vs benchmark
13%
6 trials in Phase 3/4
55%
12 of 22 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 22 completed trials
Clinical Trials (48)
An Open Label Study of the Effects and Safety of Zanubrutinib in NMOSDs Adult Patients
Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases
The Longitudinal CONQUER Study of Rare Neuroimmunologic Disorders
An Efficacy and Safety Study of Ravulizumab in Adult Participants With NMOSD
Biobank For MS And Other Demyelinating Diseases
Inectolizumab With Steroid Optimization in Newly Treated NMOSD
Evaluate the Safety and Efficacy of CAR-T Cells in the Treatment of R/R Neuromyelitis Optica
Study of the Clinical and Radiological Impact of Ravulizumab in People With Neuromyelitis Optica Spectrum Disorder
Longitudinal Cortical Demyelination in Multiple Sclerosis and Related Disorders
High Frequency Impulse Therapy for Neuropathic Pain in NMOSD
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
Safety and Efficacy of Daratumumab in Patients With Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorders
A Study of the Safety and Activity of Eculizumab in Pediatric Participants With Relapsing Neuromyelitis Optica Spectrum Disorder
FcRn Antagonists (Efgartigimod) for Acute NMOSD Attack
In Vitro Study of the Biological and Immunological Activity of Imotopes® Candidates on Blood Cells of Patients With Stabilized NMO
A Longitudinal Study of ACTEMRA® (Tocilizumab) as Monotherapy in Highly Active NMOSD
Pediatric NMOSD Observational Study
Efgartigimod in Acute Neuromyelitis Optica Spectrum Disorders
PEDIATRIC SONICS: Pediatric Study of Neuropsychology and Imaging in CNS Demyelinating Syndromes.
Neuromyelitis Optica (NMO) & Cetirizine